Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Chronic graft-versus-host disease: is there an alternative to the conventional treatment?

Bone Marrow Transplantation volume 25, pages 689–696 (2000)Cite this article

Abstract

Despite conventional and new therapies for the treatment of chronic GVHD (cGVHD), this syndrome continues to account for significant morbidity and mortality after allogeneic hematopoietic stem cell transplantation. With the expanded use of allogeneic peripheral blood stem cell transplantation, matched unrelated as well as mismatched related donors there is an increased incidence of cGVHD that poses a new clinical challenge. Over the past 10 years some new agents have been used, particularly, as a salvage therapy for the treatment of cGVHD. Many of the new agents discussed in this paper may have a role in the future as a therapy for cGVHD. Randomized clinical trials must be performed earlier in the course of cGVHD to establish the efficacy of these new drugs. Bone Marrow Transplantation (2000) 25 , 689–696.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ferrara JLM, Deeg HJ . Graft-versus-host disease New Engl J Med 1991 10: 667–674

    Google Scholar 

  2. Storek J, Gooley T, Siadak M . Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease Blood 1997 12: 4705–4709

    Google Scholar 

  3. Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassemia New Engl J Med 1990 322: 417–421

    CAS  PubMed  Google Scholar 

  4. Gaziev D, Polchi P, Galimberti M et al. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors Transplantation 1997 6: 854–860

    Google Scholar 

  5. Lazarus HM, Rowe JM . New and experimental therapies for treating graft-versus-host disease Blood Rev 1995 2: 117–133

    Google Scholar 

  6. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies Transplantation 1991 2: 443–447

    Google Scholar 

  7. Morton AJ, Anasetti C, Gooley T et al. Chronic graft-versus-host disease (GVHD) following unrelated donor transplantation Blood 1997 10: (Suppl.1) 590a (Abstr.2623)

    Google Scholar 

  8. Urbano-Ispizua A, Garcia-Conde J, Brunet S et al. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation Haematologica 1997 82: 683–689

    CAS  PubMed  Google Scholar 

  9. Neiderwieser D, Pepe M, Storb R et al. Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia Bone Marrow Transplant 1989 4: 151–156

    Google Scholar 

  10. Sullivan KM, Witherspoon RP, Storb R et al. Alternating-day cyclosporine and prednisone treatment of high-risk chronic graft-v-host disease Blood 1988 2: 555–561

    Google Scholar 

  11. Wingard JR, Piantadosi S, Vogelsang GB et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation Blood 1989 4: 1428–1435

    Google Scholar 

  12. Schiller G, Gale RP . Is there an effective therapy for chronic graft-versus-host disease? Bone Marrow Transplant 1993 11: 189–192

    CAS  PubMed  Google Scholar 

  13. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients Am J Med 1980 69: 204–217

    CAS  PubMed  Google Scholar 

  14. Sullivan KM . Acute and chronic graft-versus-host disease in man Int J Cell Cloning 1986 4: 42–93

    PubMed  Google Scholar 

  15. Shulman HM, Sale GE, Lemer KG et al. Chronic cutaneous graft-versus-host disease in man Am J Pathol 1978 91: 545–570

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Weinberg K, Annet G, Kashyap A et al. The effect of thymic function on immunocompetence following bone marrow transplantation Biol Blood Marrow Transplant 1995 1: 18–25

    CAS  PubMed  Google Scholar 

  17. Crisi GM, Tsiagbe VK, Russo C et al. Evaluation of presence and functional activity of potentially self-reactive T cells in aged mice Int Immunol 1995 8: 387–395

    Google Scholar 

  18. Parkman R . Chronic graft-versus-host disease Curr Opin Hematol 1998 5: 22–25

    CAS  PubMed  Google Scholar 

  19. Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression Blood 1981 2: 267–276

    Google Scholar 

  20. Sullivan KM, Witherspoon RP, Storb P et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation Blood 1988 2: 546–554

    Google Scholar 

  21. Sullivan KM, Witherspoon RP, Storb R . Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease Blood 1988 2: 555–561

    Google Scholar 

  22. Sullivan KM, Mori M, Witherspoon R et al. Alternating-day cyclosporine and prednisolone (CSP/PRED) treatment of chronic graft-versus-host disease (GVHD): predictors of survival Blood 1990 76: 568a

    Google Scholar 

  23. Sullivan KM, Goley T, Nims J et al. Comparison of cyclosporine (CSP), prednisone (PRED) or alternating-day CSP/PRED in patients with standard and high risk chronic graft-versus-host disease (GVHD) Blood 1993 10: (Suppl.1) 215a (Abstr.845)

    Google Scholar 

  24. Sullivan KM, Flowers MED, Nims J et al. Results of four regimens of salvage treatment of refractory chronic graft-versus-host disease (GVHD) Blood 1996 15: (Suppl.1) 644a (Abstr.2564)

    Google Scholar 

  25. Sheskin J . Thalidomide in the treatment of lepra reactions Clin Pharm Ther 1968 6: 303–306

    Google Scholar 

  26. Keenan RJ, Eiras G, Burkart GJ et al. Immunosuppressive properties of thalidomide Transplantation 1991 52: 908–910

    CAS  PubMed  Google Scholar 

  27. Vogelsang GB, Hess AD, Brundette GR, Santos GW . Thalidomide induction of bone marrow transplantation tolerance Transplant Proc 1987 19: 2658–2661

    CAS  PubMed  Google Scholar 

  28. Moriera AL, Sampaio EP, Znuidzinas A et al. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation J Exp Med 1993 177: 1675–1680

    Google Scholar 

  29. Vogelsang GB, Farmer ER, Hess AD et al. Thalidomide for the treatment of chronic graft-versus-host disease New Engl J Med 1992 16: 1055–1058

    Google Scholar 

  30. Heney D, Norfolk DR, Wheldon J et al. Thalidomide treatment for chronic graft-versus-host disease Br J Haematol 1991 78: 23–27

    CAS  PubMed  Google Scholar 

  31. Rovelli A, Arrigo C, Nesi F et al. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation Bone Marrow Transplant 1998 21: 577–581

    CAS  PubMed  Google Scholar 

  32. Parker PM, Chao N, Nademanee A et al. Thalidomide as salvage therapy for chronic graft-versus-host disease Blood 1995 9: 3604–3609

    Google Scholar 

  33. Eppinger T, Ehninger G, Steinert M et al. 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease Transplantation 1990 50: 807–811

    CAS  PubMed  Google Scholar 

  34. Jampel RM, Farmer ER, Vogelsang GB et al. PUVA therapy for chronic cutaneous graft-versus-host disease Arch Dermatol 1991 127: 1673–1678

    CAS  PubMed  Google Scholar 

  35. Vogelsang GB, Wolff D, Altomonte V et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA) Bone Marrow Transplant 1996 17: 1061–1067

    CAS  PubMed  Google Scholar 

  36. Lindelöf B et al. PUVA and cancer: a large-scale epidemiology study Lancet 1991 339: 91–93

    Google Scholar 

  37. Altman JS, Adler SS . Development of multiple cutaneous squamous cell carcinomas during PUVA treatment for chronic graft-versus-host disease J Am Acad Dermatol 1994 31: 505–507

    CAS  PubMed  Google Scholar 

  38. Aubin F, Brion A, Deconinck E et al. Phototherapy in the treatment of cutaneous graft-versus-host disease Transplantation 1995 1: 151–155

    Google Scholar 

  39. Atkinson K, Weller P, Rayman W, Biggs J . PUVA therapy for drug-resistant graft-versus-host disease Bone Marrow Transplant 1986 1: 227–236

    CAS  PubMed  Google Scholar 

  40. Volc-Platzer B, Hönigsmann H, Hinterberger W, Wolff K . Photochemotherapy improves chronic cutaneous graft-versus-host disease J Am Acad Dermatol 1990 23: 220–228

    CAS  PubMed  Google Scholar 

  41. Edelson R, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary result New Engl J Med 1987 316: 297–303

    CAS  PubMed  Google Scholar 

  42. Wolfe JT, Lessin SR, Anjali HS et al. Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and graft rejection Artif Organs 1994 18: 888–897

    CAS  PubMed  Google Scholar 

  43. Costanzo-Nordin MR, Hubbel EA, O'Sullivan EJ et al. Successful treatment of heart transplant rejection with photopheresis Transplantation 1992 53: 808–815

    CAS  PubMed  Google Scholar 

  44. Gerber M, Gmeinhart B, Volc-Platzer B et al. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP) Bone Marrow Transplant 1997 19: 517–519

    CAS  PubMed  Google Scholar 

  45. Owsianowski M, Gollnick H, Siegret W et al. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis Bone Marrow Transplant 1994 14: 845–848

    CAS  PubMed  Google Scholar 

  46. Rosetti F, Zulian F, Dall'Amico R et al. Extracorporeal photopheresis as single therapy for extensive, cutaneous, chronic graft-versus-host disease Transplantation 1995 59: 149–151

    Google Scholar 

  47. Perez M, Edelson R, Laroche L, Berger C . Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes J Invest Dermatol 1989 92: 669–676

    CAS  PubMed  Google Scholar 

  48. Besnier DP, Chabannes D, Mahé B et al. Treatment of graft-versus-host disease by extracorporeal photochemotherapy Transplantation 1997 1: 49–54

    Google Scholar 

  49. Dall'Amico R, Rossetti F, Zulian F et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease Br J Haematol 1997 97: 848–854

    CAS  PubMed  Google Scholar 

  50. Rabitsch W, Reiter E, Keil F et al. Extracorporeal photopheresis (ECP) in extensive chronic graft-versus-host disease (GVHD) Blood 1997 10: (Suppl.1) 376a (Abstr. 1676)

    Google Scholar 

  51. Sniecinski I, Parker P, Dagis A et al. Extracorporeal photopheresis (EP) is effective treatment for chronic refractory graft-versus-host disease (GvHD) Blood 1998 10: (Suppl.1) 454a (Abstr.1877)

    Google Scholar 

  52. Hooks MA . Tacrolimus, a new immunosuppressant – review of the literature Ann Pharmacol 1994 28: 501–511

    CAS  Google Scholar 

  53. Przepiorka D, Ippoliti C, Khouri I et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation Blood 1996 11: 4383–4389

    Google Scholar 

  54. Koehler MT, Howrie D, Mirro J et al. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation Bone Marrow Transplant 1995 15: 895–899

    CAS  PubMed  Google Scholar 

  55. Tzakis AG, Abu-Elmagd K, Fung JJ et al. FK506 rescue in chronic graft-versus-host disease after bone marrow transplantation Transplant Proc 1991 23: 3225–3227

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Kanamaru A, Takemoto Y, Kakishita E et al. FK 506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants Bone Marrow Transplant 1995 15: 885–889

    CAS  PubMed  Google Scholar 

  57. Slavin S, Reitz B, Bieber CP et al. Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts J Exp Med 1978 147: 700–707

    CAS  PubMed  Google Scholar 

  58. Strober S, Tanay A, Field E et al. Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis Ann Intern Med 1985 102: 441–449

    CAS  PubMed  Google Scholar 

  59. Socie G, Devergie A, Cosset JM et al. Low-dose (one Gray) total lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease Transplantation 1990 3: 657–658

    Google Scholar 

  60. Bullorsky EO, Shakley CM, Stemmelin GR et al. Total lymphoid irradiation for treatment of drug resistant chronic GVHD Bone Marrow Transplant 1993 11: 75–76

    CAS  PubMed  Google Scholar 

  61. Fung HC, Voss NJ, Barnet MJ et al. Low dose thoracoabdominal irradiation for treatment of advanced chronic graft-versus-host disease Blood 1995 10: (Suppl.1) 390a (Abstr.1550)

    Google Scholar 

  62. Devergie A, Grinski T, Sociè G, Gluckman E . Immunosuppressive treatment with 1Gy lymphoid irradiation for treatment of severe chronic graft-versus-host disease Blood 1996 10: (Suppl.1) 644a (Abstr.2565)

    Google Scholar 

  63. Sollinger HW . Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 1995 60: 225–243

    CAS  PubMed  Google Scholar 

  64. Basara N, Blau WI, Romer E et al. Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients Bone Marrow Transplant 1998 22: 61–65

    CAS  PubMed  Google Scholar 

  65. Nash RA, Fulong T, Storb R et al. Mycophenolate mofetil (MMF) as salvage treatment for graft-versus-host disease (GVHD) after allogeneic hematopoietic transplantation (HSCT): safety analysis Blood 1997 10: (Suppl.1) 105a (Abstr.459)

    Google Scholar 

  66. Mookerjee B, Altomonte V, Vogelsang G . Salvage therapy with mycophenolate mofetil and FK506 for refractory chronic graft-versus-host disease Blood 1998 10: (Suppl.1) 457a (Abstr.559)

    Google Scholar 

  67. Holdines MR . Clinical pharmacokinetics of clofazimine. A review Clin Pharmacol 1989 16: 74–83

    Google Scholar 

  68. Mackey JP, Barnes J . Clofazimine in the treatment of discoid lupus erythematosus Br J Dermatol 1974 91: 93–96

    CAS  PubMed  Google Scholar 

  69. Lee S, Wegner SA, McGarigle CJ et al. Treatment of chronic graft-versus-host disease with clofazimine Blood 1997 7: 2298–2302

    Google Scholar 

  70. Geiger J, Saurat J . Acitretin and etretinate. How and when they should be used Dermatol Clin 1993 121: 367–372

    Google Scholar 

  71. Marcellus DC, Altomonte VL, Farmer ER et al. Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease Blood 1999 1: 66–70

    Google Scholar 

  72. Leuchner U, Fischer H, Kurtz W et al. Ursodeoxycholic acid in primary cirrhosis: results of a controlled, double-blind trial Gastroenterology 1989 97: 1268–1274

    Google Scholar 

  73. Poupon RE, Balkau B, Eschwege E, Poupon R . A multicenter, controlled trial of ursodiol for treatment of primary cirrhosis New Engl J Med 1991 324: 1548–1554

    CAS  PubMed  Google Scholar 

  74. Calmus Y, Gane P, Rouger P, Poupon R . Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid Hepatology 1990 11: 12–15

    CAS  PubMed  Google Scholar 

  75. Fried RH, Murakami CS, Fisher LD et al. Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver Ann Intern Med 1992 116: 624–629

    CAS  PubMed  Google Scholar 

  76. Summerfield GP, Bellingam AJ, Bunch C, Woodrow JC . Successful treatment of chronic cutaneous graft-versus-host-disease (GVHD) with penicillamine Clin Lab Haemat 1983 5: 313–318

    CAS  Google Scholar 

  77. Lönnqvist B, Carneskog J . Cyclophenile in 9 cases of severe sclerotic chGVHD of the skin Bone Marrow Transplant 1998 21: (Suppl.1) S112 (Abstr. 387)

    Google Scholar 

  78. Levi-Schaffer F, Nagler A, Slavin S et al. Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of haloginone J Invest Dermatol 1996 106: 84–88

    CAS  PubMed  Google Scholar 

  79. Claman HN, Lee Choi K, Sujansky W, Vatter AE . Mast cell ‘disappearance’ in chronic murine graft-versus-host disease (GVHD) – ultrastructural demonstration of ‘phantom’ mast cells J Immunol 1986 137: 2009–2013

    CAS  PubMed  Google Scholar 

  80. Levi-Schaffer F, Goldenhersh MA, Segal V, Nagler A . Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease Bone Marrow Transplant 1997 19: 823–828

    CAS  PubMed  Google Scholar 

  81. Sullivan KM, Mori M, Sanders J et al. Late complications of allogeneic and autologous marrow transplantation Bone Marrow Transplant 1992 10: (Suppl.1) 127–134

    PubMed  Google Scholar 

  82. Meyers JD . Infection in bone marrow transplant recipients Am J Med 1986 81: 27–38

    CAS  PubMed  Google Scholar 

  83. Lum LG . The kinetics of immune reconstitution after human marrow transplant Blood 1987 69: 369–380

    CAS  PubMed  Google Scholar 

  84. Kahls P, Panzer S, Kletter K et al. Functional asplenia after bone marrow transplantation: a late complication related to extensive chronic graft versus host disease Ann Intern Med 1988 109: 461–464

    Google Scholar 

  85. Rege K, Mehta J, Treleaven J et al. Fatal pneumococcal infections following allogeneic bone marrow transplantation Bone Marrow Transplant 1994 14: 903–906

    CAS  PubMed  Google Scholar 

  86. Singhal S, Mehta J . Reimmunization after blood or marrow stem cell transplantation Bone Marrow Transplant 1999 23: 637–646

    CAS  PubMed  Google Scholar 

  87. Storb R, Deeg JH, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia New Engl J Med 1986 314: 729–735

    CAS  PubMed  Google Scholar 

  88. Chao NJ, Schmidt GM, Niland JC et al. Cyclosporin, methotrexate, and prednisone compared with cyclosporin and prednisone for prophylaxis of acute graft-versus-host disease New Engl J Med 1993 329: 1225–1230

    CAS  PubMed  Google Scholar 

  89. Lönnqvist B, Aschan J, Ljugman P, Ringdèn O . Long-term cyclosporine therapy may decrease the risk of chronic graft-versus-host disease Br J Haematol 1990 4: 547–548

    Google Scholar 

  90. Tiberghien P . ‘Suicide’ gene for the control of graft-versus-host disease Curr Opin Hematol 1998 5: 478–482

    CAS  PubMed  Google Scholar 

  91. Bonini C, Ferrari G, Verzeletti S et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 1997 276: 1719–1724

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ms Law Aileen, member of our nursing staff, for linguistic assistance. This work has been supported by the Berloni Foundation against Thalassemia, Pesaro and by the Italian Association against Leukemia Pesaro Section.

Author information

Authors and Affiliations

  1. Divisione di Ematologia e Centro Trapianti di Midollo Osseo di Muraglia, Azienda Ospedaliera di Pesaro, Pesaro, Italy

    D Gaziev, M Galimberti, G Lucarelli & P Polchi

Authors
  1. D Gaziev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Galimberti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Lucarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Polchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaziev, D., Galimberti, M., Lucarelli, G. et al. Chronic graft-versus-host disease: is there an alternative to the conventional treatment?. Bone Marrow Transplant 25, 689–696 (2000). https://doi.org/10.1038/sj.bmt.1702235

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702235

Keywords

This article is cited by

Search

Advanced search

Quick links